ARCUS BIOSCIENCES, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.12 USD | -1.20% |
|
-1.27% | -14.35% |
EPS & Dividend: Arcus Biosciences, Inc.
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.93 | -2.24 | 0.71 | -3.71 | -4.15 | -3.053 | -4.805 | -3.564 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 10.10 | 25.96 | 40.47 | 20.68 | 19.10 | 16.31 | 16.31 | 16.31 |
| Nbr of stocks (in thousands) | 45,859 | 64,923 | 70,249 | 72,408 | 74,856 | 91,428 | - | - |
| Announcement Date | 05/03/20 | 24/02/21 | 23/02/22 | 28/02/23 | 21/02/24 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Arcus Biosciences, Inc.
More events
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -5.34x | 3.262 | 2.33x | ||
| +0.85% | +0.98% | 47.36x | 4.065 | 6.29x | ||
| -.--% | -.--% | 31.26x | 6.276 | 3.6x | ||
| -.--% | -.--% | -104.49x | 121.73 | 14.03x | ||
| +0.26% | +0.26% | 74.54x | 2.356 | 11.37x | ||
| -.--% | -.--% | -8.34x | 2.802 | 6.95x | ||
| -.--% | -.--% | 32.3x | 2.461 | 3.18x | ||
| -.--% | -.--% | 14.09x | 2.086 | 4.66x | ||
| +0.44% | +0.46% | 60x | 4.901 | 9.31x | ||
| -.--% | -.--% | 29.29x | 11.03 | 4.57x | ||
| Average | +0.15% | +0.17% | 17.07x | 16.1 | 6.63x | |
| Weighted average by Cap. | +0.21% | +0.24% | 16.81x | 19.74 | 7.15x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition